We studied the tumor-wide communication among cells in tumors of post-menopausal women with node positive or > 2 cm ER+ and/or PR+ , HER2 negative breast cancer enrolled on the FELINE clinical trial10,31,32 (clinicaltrials.gov # NCT02712723). Here, ERBB2 is linked to neoplasm.